Cubist Systematic Strategies’s Xenon Pharmaceuticals XENE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,105
Closed -$220K 2709
2024
Q1
$220K Buy
+5,105
New +$220K ﹤0.01% 1643
2023
Q2
Sell
-1,955
Closed -$70K 3081
2023
Q1
$70K Buy
1,955
+1,778
+1,005% +$63.6K ﹤0.01% 2471
2022
Q4
$6.98K Sell
177
-20,034
-99% -$790K ﹤0.01% 3103
2022
Q3
$730K Sell
20,211
-32,467
-62% -$1.17M ﹤0.01% 2274
2022
Q2
$1.6M Sell
52,678
-21,361
-29% -$650K 0.01% 1747
2022
Q1
$2.26M Buy
74,039
+59,498
+409% +$1.82M 0.02% 1383
2021
Q4
$454K Buy
14,541
+6,653
+84% +$208K ﹤0.01% 2519
2021
Q3
$121K Buy
7,888
+6,047
+328% +$92.8K ﹤0.01% 2709
2021
Q2
$34K Sell
1,841
-3,770
-67% -$69.6K ﹤0.01% 2820
2021
Q1
$100K Sell
5,611
-382
-6% -$6.81K ﹤0.01% 2644
2020
Q4
$92K Buy
5,993
+173
+3% +$2.66K ﹤0.01% 2417
2020
Q3
$64K Sell
5,820
-9,590
-62% -$105K ﹤0.01% 2344
2020
Q2
$193K Sell
15,410
-897
-6% -$11.2K ﹤0.01% 2050
2020
Q1
$185K Sell
16,307
-9,208
-36% -$104K 0.01% 1763
2019
Q4
$335K Buy
25,515
+23,871
+1,452% +$313K 0.01% 1782
2019
Q3
$15K Sell
1,644
-2,826
-63% -$25.8K ﹤0.01% 2133
2019
Q2
$44K Sell
4,470
-2,690
-38% -$26.5K ﹤0.01% 2337
2019
Q1
$73K Buy
7,160
+675
+10% +$6.88K ﹤0.01% 2050
2018
Q4
$41K Buy
+6,485
New +$41K ﹤0.01% 1893
2018
Q3
Sell
-600
Closed -$6K 2091
2018
Q2
$6K Sell
600
-1,600
-73% -$16K ﹤0.01% 1734
2018
Q1
$11K Buy
2,200
+2,100
+2,100% +$10.5K ﹤0.01% 1772
2017
Q4
$0 Buy
+100
New ﹤0.01% 2121
2015
Q4
Sell
-1,440
Closed -$12K 1971
2015
Q3
$12K Sell
1,440
-1,738
-55% -$14.5K ﹤0.01% 1805
2015
Q2
$37K Buy
3,178
+1,089
+52% +$12.7K ﹤0.01% 1728
2015
Q1
$35K Buy
+2,089
New +$35K ﹤0.01% 1790